These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8290008)

  • 1. Alport syndrome with type I membranoproliferative glomerulonephritis.
    Meroni M; Sessa A; Battini G; Torri Tarelli L; Bertani T; Renieri A; Seri M; De Marchi M
    Nephron; 1993; 65(3):479-80. PubMed ID: 8290008
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molecular genetics of Alport syndrome].
    Yamazaki H; Saito A; Nakagawa Y; Arakawa M
    Nihon Rinsho; 1992 Dec; 50(12):3021-6. PubMed ID: 1491454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alport syndrome or progressive hereditary nephritis with hearing loss].
    Gubler MC; Heidet L; Antignac C
    Nephrol Ther; 2007 Jun; 3(3):113-20. PubMed ID: 17540313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in Alport syndrome associated with diffuse esophageal leiomyomatosis.
    Antignac C; Heidet L
    Contrib Nephrol; 1996; 117():172-82. PubMed ID: 8801045
    [No Abstract]   [Full Text] [Related]  

  • 5. Alport syndrome with a peculiar pattern of distribution of the alpha3-alpha6 chains of type IV collagen in renal basement membrane.
    Fujieda M; Endo F; Morisawa Y; Naito I; Sado Y; Nomura S; Kurashige T
    Nephron; 1998 Sep; 80(1):115-7. PubMed ID: 9730729
    [No Abstract]   [Full Text] [Related]  

  • 6. Lens coloboma and Alport-like glomerulonephritis.
    Amari F; Segawa K; Ando F
    Eur J Ophthalmol; 1994; 4(3):181-3. PubMed ID: 7819734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alport syndrome with diffuse leiomyomatosis. When and when not?
    Miner JH
    Am J Pathol; 1999 Jun; 154(6):1633-5. PubMed ID: 10362786
    [No Abstract]   [Full Text] [Related]  

  • 8. Crescentic and necrotising glomerulonephritis: a rare histological manifestation of Alport syndrome.
    Moyano Crespo GD; Torres AI; Mukdsi JH
    J Clin Pathol; 2015 Jul; 68(7):581-3. PubMed ID: 25869794
    [No Abstract]   [Full Text] [Related]  

  • 9. Familial membranoproliferative glomerulonephritis type III.
    Neary J; Dorman A; Campbell E; Keogan M; Conlon P
    Am J Kidney Dis; 2002 Jul; 40(1):E1. PubMed ID: 12087587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal dominant nephritis with renal failure of non-Alport type: clinical and molecular studies.
    Ilan T; Shohat T; Tobar A; Magal N; Yahav M; Halpern GJ; Rechavi G; Shohat M
    Isr Med Assoc J; 2001 Jul; 3(7):488-91. PubMed ID: 11791413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alport syndrome and diffuse leiomyomatosis with major morbid events presenting at adult age.
    Van Loo A; Vanholder R; Buytaert I; De Paepe A; Praet M; Elewaut A; Lameire N
    Nephrol Dial Transplant; 1997 Apr; 12(4):776-80. PubMed ID: 9141011
    [No Abstract]   [Full Text] [Related]  

  • 12. Alport syndrome and diffuse leiomyomatosis. Clinical aspects, pathology, molecular biology and extracellular matrix studies. A synthesis.
    Garcia-Torres R; Cruz D; Orozco L; Heidet L; Gubler MC
    Nephrologie; 2000; 21(1):9-12. PubMed ID: 10730274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Familial hematuric nephropathies].
    Gubler MC
    Rev Prat; 1997 Sep; 47(14):1545-9. PubMed ID: 9366112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis between X-linked Alport syndrome and thin basement membrane nephropathy.
    Rizzoni G; Massella L
    Kidney Int; 2004 Sep; 66(3):1289-90; author reply 1290. PubMed ID: 15327434
    [No Abstract]   [Full Text] [Related]  

  • 15. Retinal lesions specific for membranoproliferative glomerulonephritis type II: description of 2 cases.
    Di Maggio A; Loperfido A; Scatizzi A
    Nephron; 1993; 63(3):365-6. PubMed ID: 8446284
    [No Abstract]   [Full Text] [Related]  

  • 16. Characteristic ultrastructural lesion of the glomerular basement membrane in progressive hereditary nephritis (Alport's syndrome).
    Hinglais N; Grünfeld JP; Bois E
    Lab Invest; 1972 Nov; 27(5):473-87. PubMed ID: 4653971
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and molecular diagnosis of Alport syndrome.
    Kashtan CE
    Proc Assoc Am Physicians; 1995 Oct; 107(3):306-13. PubMed ID: 8608415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between CD36 expression, foamy cell aggregates in renal interstitium and serum cholesterol level].
    Su H; Zhu HY; Liu JS; Deng AG; Li ZQ
    Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):42-3. PubMed ID: 21429358
    [No Abstract]   [Full Text] [Related]  

  • 19. de-novo Alport syndrome: for the diagnosis of inherited glomerulonephritis with neither any family history nor extrarenal manifestation.
    Fukushima T; Nomura S; Kawai S; Osawa G
    Clin Nephrol; 1997 Aug; 48(2):134-5. PubMed ID: 9285155
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical and pathological features of Alport syndrome in children].
    Zhu CH; Huang SM; Wu HM; Bao HY; Chen Y; Han Y; Zhao F; Zhang AH; Zhang WZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Mar; 12(3):188-91. PubMed ID: 20350427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.